NCT03929198 (Prit-TN) is a NA clinical trial of Healthy Lifestyle in Metabolic Syndrome, sponsored by Washington University School of Medicine.

Who is sponsoring NCT03929198?

NCT03929198 is sponsored by Washington University School of Medicine.

What drugs are being tested in NCT03929198?

Interventions in NCT03929198: Healthy Lifestyle.

What condition does NCT03929198 study?

NCT03929198 studies Metabolic Syndrome, Obesity, Weight Loss, Hypertension, Hypercholesterolemia, Hypertriglyceridemia.

Is NCT03929198 still recruiting?

NCT03929198 is currently completed. Last updated 8 May 2019.

Last reviewed 2019-05-08 · How we verify

NCT03929198: Prit-TN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Translation of Pritikin Program to the Community

Completed NA Last updated 8 May 2019

What this trial tests

NA trial testing Healthy Lifestyle in Metabolic Syndrome in 54 participants. Completed in 1 December 2018.

Timeline

27 September 2018

Primary endpoint
20 November 2018

1 December 2018

Quick facts

Lead sponsor	Washington University School of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	54
Start date	27 September 2018
Primary completion	20 November 2018
Estimated completion	1 December 2018
Sites	1 location across United States

Drugs / interventions tested

Healthy Lifestyle

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →
Obesity — all drugs for Obesity →
Weight Loss — all drugs for Weight Loss →
Hypertension — all drugs for Hypertension →

Sponsor

Washington University School of Medicine

Who can join

18 and older, any sex, with Metabolic Syndrome or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The broad, long-term aims of this scope of work are to investigate the effects of the Pritikin Program to the general population. The study will test the effects on individuals from the community with dysfunctional lipids, blood pressure and glycemic control. To assess the effectiveness of the Pritikin Program in the community, the effects of Pritikin lifestyle intervention on overall health will be investigated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Short-term Intensive Lifestyle Therapy in a Worksite Setting Improves Cardiometabolic Health in People With Obesity.
Schweitzer GG, Beckner DC, Smith GI, Klein S. · · 2023 · cited 2× · PMID 37153109 · DOI 10.1210/jendso/bvad048

Verify or expand the search:

Other trials of Healthy Lifestyle

Trials testing the same drug.

NCT05936385 — Mobile Integrated Care for Childhood Obesity · NA · completed
NCT04221750 — Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors · Phase 3 · completed
NCT04556175 — Great Beginnings for Healthy Native Smiles: An Early Childhood Caries Prevention Project · NA · terminated
NCT04275869 — Internet-based Intervention to Promote a Healthy Lifestyle on the Reproductive Parameters of Overweight and Obese Women · NA · withdrawn
NCT04234009 — Lifestyle and Brain Vascular Function · NA · terminated

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Other Washington University School of Medicine trials

Trials by the same sponsor.

NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03929198 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
Last refreshed: 8 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03929198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing